Answers are grounded in this paper and cite their sources.
There are several physiological and pharmacological actions of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide for the regulation of blood glucose and bodyweight.
No takes yet. Share an insight, caveat, or question.
Zenimaru et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: